Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma

Molecular Carcinogenesis

Volumn 56, Issue 3, 2017, Pages 1041-1054

  Chak, Wing Po ^a,b   Lung, Raymond Wai Ming ^a,b   Tong, Joanna Hung Man ^a,b   Chan, Sylvia Yat Yee ^a,b   Lun, Samantha Wei Man ^a,b   Tsao, Sai Wah ^c   Lo, Kwok Wai ^a,b   To, Ka Fai ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

lncRNA; MEG3; NPC; promoter hypermethylation; tumor suppression

Indexed keywords

LONG UNTRANSLATED RNA; MATERNALLY EXPRESSED GENE 3; MATERNALLY EXPRESSED GENE 3 AF; MATERNALLY EXPRESSED GENE 3 BX; PROTEIN P53; UNCLASSIFIED DRUG; MEG3 NON-CODING RNA, HUMAN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE ARREST; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; ECTOPIC EXPRESSION; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE INACTIVATION; GENETIC REGULATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HEAD AND NECK CANCER CELL LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; INTRACELLULAR SIGNALING; LUCIFERASE ASSAY; METHYLATION; MOLECULAR CLONING; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA; CELL CYCLE; CHROMOSOME 14; COPY NUMBER VARIATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; GENOME IMPRINTING; NASOPHARYNX TUMOR; PROMOTER REGION; TUMOR CELL LINE;

ANIMALS; CARCINOMA; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 14; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC IMPRINTING; HUMANS; MICE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS, GENETIC; RNA, LONG NONCODING;

EID: 84991833036     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22569     Document Type: Article

References (41)

1. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004; 5:423–428.
2. Lo KW, Chung GT, To KF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol 2012; 22:79–86.
3. Chen SJ, Chen GH, Chen YH, et al. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS ONE 2010; e12745.
4. Lung RW, Tong JH, To KF. Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy. Int J Mol Sci 2013; 14:17378–17409.
5. Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol 2015; 235:323–333.
6. Cai LM, Lyu XM, Luo WR, et al. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 2015; 34:2156–2166.
7. Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ, Chen HC. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog 2014; 10:e1003974.
8. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 2012; 31:2207–2221.
9. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 10:38.
10. Gutschner T, Diederichs S. The hallmarks of cancer: A long non-coding RNA point of view. RNA Biol 2012; 9:703–719.
11. Lo KW, Teo PM, Hui AB, et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000; 60:3348–3353.
12. Cheung AK, Ko JM, Lung HL, et al. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci USA 2011; 108:8390–8395.
13. Ko JM, Yau WL, Chan PL, et al. Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32. Genes Chromosomes Cancer 2005; 43:284–293.
14. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464:1071–1076.
15. Chung GT, Lung RW, Hui AB, et al. Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma. J Pathol 2013; 231:158–167.
16. Zhang X, Zhou Y, Mehta KR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 2003; 88:5119–5126.
17. Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 2011; 129:773–779.
18. Tong JH, Ng DC, Chau SL, et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 2010; 10:253.
19. Yip YL, Pang PS, Deng W, et al. Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study. PLoS ONE 2013; 8:e78395.
20. To KF, Tong JH, Yeung KS, et al. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant. J Thorac Oncol 2013; 8:883–891.
21. Tong JH, Lung RW, Sin FM, et al. Characterization of rare transforming KRAS mutations in sporadic colorectal cancer. Cancer Biol Ther 2014; 15:768–776.
22. Lung RW, Tong JH, Sung YM, et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 2009; 11:1174–1184.
23. Lee N, Pimienta G, Steitz JA. AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus. RNA 2012; 18:2073–2082.
24. Miyoshi N, Wagatsuma H, Wakana S, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells 2000; 5:211–220.
25. Zhou Y, Zhong Y, Wang Y, et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem 2007; 282:24731–24742.
26. Bo H, Gong Z, Zhang W, et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget 2015; 6:20404–20418.
27. Yan J, Guo X, Xia J, et al. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1. Med Oncol 2014; 31:879.
28. Jia LF, Wei SB, Gan YH, et al. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer 2014; 135:2282–2293.
29. Zamani M, Sadeghizadeh M, Behmanesh M, Najafi F. Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer. Phytomedicine 2015; 22:961–967.
30. Voon YL, Ahmad M, Wong PF, et al. Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity. Oncol Rep 2015; 34:1692–1700.
31. Lung RW, Wang X, Tong JH, et al. A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma. Mol Carcinog 2013; 52:E28–E38.
32. Barak Y, Juven T, Haffner R, Oren M. Mdm2 expression is induced by p53 activity. EMBO J 1993; 12:461–468.
33. Wang SP, Wang WL, Chang YL, et al. P53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 2009; 11:694–704.
34. Ohkubo S, Tanaka T, Taya Y, Kitazato K, Prives C. Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. J Biol Chem 2006; 281:16943–16950.
35. Dang J, Kuo ML, Eischen CM, Stepanova L, Sherr CJ, Roussel MF. The RING domain of Mdm2 can inhibit cell proliferation. Cancer Res 2002; 62:1222–1230.
36. Giono LE, Manfredi JJ. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest. Mol Cell Biol 2007; 27:4166–4178.
37. Geyer RK, Yu ZK, Maki CG. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2000; 2:569–573.
38. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005; 309:1732–1735.
39. Bonasio R, Shiekhattar R. Regulation of transcription by long noncoding RNAs. Annu Rev Genet 2014; 48:433–455.
40. Kaneko S, Bonasio R, Saldana-Meyer R, et al. Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol Cell 2014; 53:290–300.
41. Mondal T, Subhash S, Vaid R, et al. MEG3 long noncoding RNA regulates the TGF-beta pathway genes through formation of RNA-DNA triplex structures. Nat Commun 2015; 6:7743.